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Background: Thymic stromal lymphopoietin (TSLP) is an epithelial cell-derived cytokine, implicated in the development
and progression of allergic diseases. Recent studies have demonstrated significantly increased expression and synthesis of
TSLPin nasal mucosa of patients with allergic rhinitis (AR), compared with nonallergic control subjects. Also, there is
significant correlation between the level of TSLP mRNA and symptom severity in AR patients. In this study, we investigated
whether polymorphisms in the TSLP gene were associated with increased risk of AR in the Chinese population.
Methods: In a candidate gene association study, we tested 11 single nucleotide polymorphisms (SNPs) in the TSLP gene in
368 AR and 325 control adult Han Chinese subjects from Beijing. The 11 SNPs were selected from the Chinese HapMap
genotyping dataset to ensure complete genetic coverage. AR was established by questionnaire and clinical examination,
and blood was drawn from all subjects for DNA extraction. The PLINK software package was used to perform statistical
testing.
Results: In the single-locus analysis of AR risk, no significant differences in allele and genotype frequencies were found
between AR and control subjects. Further logistic regression analyses adjusted for age and gender also failed to reveal
significant associations between AR and the selected SNPs. Similarly, analysis stratified by gender, and haplotype or diplotype
did not reveal any association with AR risk.
Conclusion: Although TSLP presents itself as a good candidate for contributing to allergy, this study failed to find an
association between specific SNPs in the TSLP gene and AR susceptibility in the Han Chinese population.
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Allergic rhinitis (AR) is an inflammatory disease of the
nasal mucosa induced by an immunoglobulin E (IgE)-
mediated reaction in allergen-sensitized subjects. AR has
increased in prevalence over the last decade, in particu-
larly the industrialized nations, and currently affects up
to 40% of the population worldwide [1]. Recent data* Correspondence: dr.luozhang@gmail.com
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reproduction in any medium, provided the orfrom mainland China indicates that the prevalence of
self-reported AR in major cities across China is high and
ranges between 8.7%-24.1%; with around 25% of all
patients suffering from persistent symptoms [2].
There is a plethora of evidence, which suggests that
the airway epithelial cells are likely to play an important
role in the aetiology of AR, particularly as they represent
the first line of defense against inhaled microbes and for-
eign antigens and are capable of initiating and control-
ling immune responses by influencing the expression,
synthesis and release of a variety of mediators that play a
critical role in shaping and driving allergic inflammatory
responses [3,4]. In this regard, thymic stromal lympho-
poietin (TSLP) is an important epithelial cell-derivedLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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thymus [5], and has been referred to as a “master
switch” of allergic inflammation at the epithelial cell
and dendritic cell interface [6]. Indeed, several studies
in humans and mouse models have implicated TSLP
in the development and progression of allergic dis-
eases, including atopic dermatitis [7–10], asthma [11–
13] and AR [14–16]. Moreover, recent studies in Chin-
ese subjects have demonstrated that the expression of
TSLPmRNA and/or TSLP protein was significantly
increased in the nasal mucosa/epithelia cells of patients
with AR compared with the nonallergic control sub-
jects [14,17], and there was significant correlation
between the level of TSLP mRNA and symptom severity
in AR patients [17].
In view of this evidence, we hypothesized that the
TSLP gene is a strong candidate gene, which may influ-
ence an individual’s risk to develop AR. The aim of this
study was therefore to examine whether polymorphisms
in the TSLP gene are associated with an individual’s sus-
ceptibility to develop AR in a Han Chinese cohort.
Methods
A population-based case–control association study de-
sign was used to assess the risk of AR conferred by SNPs
in TSLP gene regions.
Study subjects
Three hundred and sixty-eight adult subjects suffering
from AR were recruited from the outpatient clinic of
Otolaryngology, Head and Neck Surgery Department at
Beijing Tongren Hospital, during February 2010 to
November 2010.
All subjects had a history of AR for at least 1 year and
fulfilled all of the Allergic Rhinitis and its Impact on
Asthma (ARIA) guidelines [18] criteria for AR; including i)
presence of persistent or discontinuous symptoms of an-
terior rhinorrhea, continuous sneezing, nasal obstruction
and itching, ii) demonstration of a pale and edematous
nasal mucosa, nasal discharge and swollen inferior turbi-
nates by nasal endoscopy, and iii) positive skin prick test
(SPT) to a panel of common allergens as shown below
(Allergopharma, Reinbeck, Germany) and/or positive
serum antigen-specific IgE, measured by the ImmunoCAP
100 system (Pharmacia, Uppsala, Sweden). A diagnosis of
AR was further confirmed by the presence of symptoms
induced by exposure to an allergen shown to produce a
strong positive skin test response.
The tested antigens included house dust mite (HDM)
(Der f and Der p); seasonal grass pollens (Giant Rag-
weed; Mugwort; Lamb’s quarers; Humulus; Chenopo-
dium album); animal hair (especially dog and cat); molds
(indoor and outdoor mustiness or floricultural environ-
ment) and cockroach. A positive SPT result was definedas a wheal greater than or equal to one half of the diam-
eter of the histamine control and at least 3 mm larger
than the diameter of the negative control [19]. Subjects
were also considered to be sensitized to allergens when
the serum IgE was ≥0.35 kU/l.
AR subjects with i) co-morbid asthma, eczema, or any
other allergic disease; ii) hypertension, diabetes or other
chronic diseases; or iii) tumor in the nasal cavity or any
other inflammatory nasal disease were excluded. The
diagnosis of asthma was confirmed by a chest physician
according to Global Initiative for Asthma (GINA) guide-
lines [20].
A total of 325 adult healthy control volunteers were
also recruited from an ethnically similar local population
to determine background population allele frequencies.
None of these subjects had a history of allergic or any
nasal disease, nor demonstrated any abnormal clinical
features in the nasal cavity, or a positive SPT to any of
the common allergens as shown above.
All subjects were ethnic Han Chinese, who had lived
in the Beijing region, China, over long periods and pro-
vided written informed consent prior to entry in the
study. The study protocol was approved by the Ethics
Committee of Beijing Tongren Hospital and performed
in accordance with the guidelines of the World Medical
Association’s Declaration of Helsinki.Selection of polymorphisms in the human TSLP gene
The International Haplotype Mapping (HapMap) (www.
hapmap.org) SNP databases were used to select tSNPs in
the TSLP gene region. The screened region extended 10
kilobases upstream of the annotated transcription start
site and downstream at the end of the last exon in the
gene. The tSNPs were selected to extract most genetic
information in the region using the CHB genotyping
data from the HapMap database (HapMap data rel 27
Phase II + III, Feb2009) [21]. Genotyping data was obtained
for 25tSNPs for TSLP in this dataset and loaded in the
Haploview software version 4.2 (http://www.broad.mit.edu/
haploview/haploview-downloads ) [22]. Further selection of
the eventual tSNPs to be investigated was made using a
pair-wise tagging algorithm [22]; setting the Hardy-
Weinberg p value, minor allele frequency (MAF), and r2
threshold values at 0.01, 0.05 and 0.8, respectively. The
linkage disequilibrium (LD) pattern of the TSLP gene in
the CHB population exhibited strong LD in several
groups of tSNPs (r2 greater than or equal to 0.8), indicat-
ing that the most common SNPs could be captured by a
subset of tagging SNPs [23]. Subsequently, 11TSLP gene
SNPs (including rs1545169, rs764917, rs12653736, rs1837253,
rs12654933, rs10455025, rs11466741, rs13156086, rs6886755,
rs252706 and rs2416259) were selected to represent the
entire 25 loci for genotyping.
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DNA was isolated from peripheral blood leukocytes
using the DNA Isolation Kit for Mammalian Blood
(Roche, Indianapolis, USA), and stored at 4°C prior to
further investigation within 2 days.Genotyping of the
selected SNP was performed using iPLEX chemistry on
a matrix-assisted laser desorption/ ionization time-
of-flight mass spectrometer (Sequenom, San Diego,
California) according to the manufacturer’s instructions
[24]. The polymerase chain reaction (PCR) and exten-
sion primers were designed using MassARRAY Assay
Design 4.0 software (Additional file 1: Table S1).
PCR was carried out in standard 384-well plates, using
5 μL of a reaction mix comprising 10 ng of genomic
DNA, 0.5 units of Taq polymerase (HotStarTaq, Qiagen),
500 μmol of each deoxynucleotide triphosphate, and
100 nmol of each primer per well. PCR thermal cycling
was carried out in an ABI-9700 instrument (Gen-
eAmpPCR system 9700, ABI, California) for 15 min at
94°C, followed by 45 cycles of 20 s at 94°C, 30 s at 56°C,
and 60 s at 72°C. At the end of cycling, 2 μL of a solu-
tion containing 0.3 units of shrimp alkaline phosphatase
was added to each well and the reaction was incubated
at 37°C for 20 min, and then at 85°C for 5 min to ter-
minate the reaction.
After adjusting the concentrations of extension pri-
mers to equilibrate signal-to-noise ratios, the post-PCR
primer extension reaction of the iPLEX assay was carried
out in a final volume of 9 μL extension reaction mixture
containing 0.2 μL of termination mix, 0.04 μL of DNA
polymerase (Sequenom, Inc.), and 625 to 1,250 nmol/L
extension primers. A 200-short-cycle program was used
for the iPLEX reaction; involving an initial denaturation
by incubation for 30 s at 94°C, followed by incubation
for 5 s at 94°C, five cycles of 5 s at 52°C, and 5 s at 80°C.
Forty additional annealing and extension cycles were
looped back to 5 s at 94°C, five cycles of 5 s at 52°C and
5 s at 80°C, and the final extension was carried out at
72°C for 3 min. The final reaction mixture was cooled to
4°C and each sample was desalted using 6 mg of clean
resin and a dimple plate. The final product was trans-
ferred to a 384-well Spectro-CHIP (Sequenom, Inc.), and
analyzed in a Compact Mass Spectrometer, using the
MassARRAYTyper4.0 Software. The PCR assay was
arrayed with two no-template controls and four dupli-
cated samples in each 384-well format as quality con-
trols. All genotyping results were generated and checked
by an investigator blinded to the clinical status of the
subject from whom the sample was derived.
Statistical analyses
Data were initially processed for suitability for further stat-
istical evaluation using the Haploview version 4.2software.
Hardy-Weinberg equilibrium (HWE) of each SNP wasassessed in controls only and a threshold P <0.001 was
regarded to indicate deviation from the HWE. The data
were filtered further by additionally assessing the minor
allele frequency (MAF), non-missing genotype percentage
and other criteria in both the AR patients and control sub-
jects; after setting the MAF and non-missing genotype
percentage thresholds at <0.001 and <95%, respectively.
Differences in frequencies of the alleles and genotypes
between the AR subjects and control subjects were evalu-
ated using the chi-square test and HWE was tested by
the chi-square test for goodness of fit according to the
web-based program: http://ihg.gsf.de/cgi-bin/hw/hwa1.pl.
A P-value of 0.05 was considered significant. Akaike’s in-
formation criteria (AIC) were used to select the most parsi-
monious genetic model for each SNP. Odds ratios (ORs)
and 95% confidence intervals (CIs) were calculated by
unconditional logistic regression analysis, adjusted for age
and gender. Stratification analyses were also performed by
variables of interest, such as gender. These analyses were
conducted using the STATA statistical package (version 11.0;
Stata Corp LP, College Station, TX, USA).
The pair-wise linkage disequilibrium (LD) among the
SNPs was examined using Lewontin’s standardized coef-
ficient D’ and LD coefficient r2 [25], and haplotype
blocks were defined by the method of Gabriel et al. [26]
in Haploview 4.2 with default settings. The population
as a whole, including AR patients and controls, were uti-
lized in block definition. The HAPLO.STATS package in
software language R developed by Schaidand colleagues
[27] (www.mayo.edu/hsr/Sfunc.html) was used for the
haplotype analysis and PHASE 2.1 Bayesian algorithm
[28] was used to estimate the haplotype frequencies.
Haplotypes with a frequency of less than 0.03 were
pooled into a combined group and empirical P-values
based on 100,000 simulations were computed for the
global and individual haplotype score tests. Diplotype
(haplotype dosage, an estimate of the number of copies
of the haplotype) was the most probable haplotype pair
for each individual. Unconditional logistic regression
analyses, adjusted for age and gender, were conducted to
estimate ORs and 95% CIs for participants carrying one
to two copies versus zero copy of each common haplo-
type for the dichotomized diplotypes.
The statistical power for the study was calculated using
G*Power 2 software (http://www.psycho.uni-duesseldorf.
de/aap/projects/gpower/). The statistical power for com-
parison of AR vs. control was 95.01%, with the sample size
of 368 AR patients and 325 controls; the α was 0.05 and
the β was 0.2.
Results
Population characteristics
The demographic characteristics of the study population
are shown in Table 1. Both the AR and control groups
Table 1 Demographic characteristics of the study population
Demographic index AR (n = 368) Controls (n = 325)
Age Mean (Range) (years) 27.08 ± 0.77 (18–71) 36.22 ± 0.84 (18–78)
Sex, Male/Female, No. (%) 227 (60.1) /151 (39.9) 175 (53.0) / 155 (47.0)
Total IgE Mean (Range), kU/l 325.35± 31.70 (6.9-5000) 69.14 ± 9.35 (2–906)
AR=Allergic rhinitis subjects.
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group consisted of more males (60.05%) than females
(39.95%). In contrast there were approximately equal
numbers of males and females in the control group
(53.54% vs 46.46% m/f). The Pearson Chi-Square test of
the ratios for male/female between the control and AR
groups showed that these were not significantly different
(P = 0.084). The mean total serum IgE measurements for
AR and control groups were 325.35 ± 31.70 and
69.14 ± 9.35 IU/ml respectively.Individual SNP association analysis
The initial quality tests for the SNPs in the TSLP gene
selected for genotyping demonstrated that two SNPs
(rs1545169and rs764917) were not suitable for study, as
indicated by significant deviation from the Hardy–Wein-
berg equilibrium (HWE) threshold of P <0.001 (Table 2).
The data for these two loci were therefore excluded from
further analyses, and overall a total of nine SNPs
(Table 2) from chromosome 5q22.1 were chosen for fur-
ther assessment. In single-locus analyses for AR risk, the
allele frequencies for any of the nine selected tag SNPsTable 2 SNPs genotyped for TSLPgene
Gene:
locus and
OMIMNo.a
No. SNP_ID Chromosome
Positionb
Intermarker
distances
(bp)
Geni
locat
1 rs1545169 110427275 —— 50 ne
2 rs764917 110428406 1131 50 ne
3 rs12653736 110428526 120 50 ne
4 rs1837253 110429771 1245 50 ne
5 rs12654933 110430654 883 50 ne
6 rs10455025 110432898 2244 50 ne
TSLP: 5q22.1 7 rs11466741 110436604 3706 Intron
8 rs13156086 110443368 6764 30 ne
9 rs6886755 110443500 132 30 ne
10 rs252706 110444759 1259 30 ne
11 rs2416259 110447641 2882 30 ne
a. OMIM, Online Mendelian Inheritance in Man (http://www.ncbi.nlm.nih.gov/Omim
b. SNP position in Chromosome 5 in the NCBIdbSNP database (http://www.ncbi.nlm
c. MAF, minor allele frequency.
d. MAF for Chinese in the NCBIdb SNPs database.
e. allergic rhinitis subjects.
f. P value for difference in allele distributions between allergic rhinitis and control s
g. HWE, Hardy–Weinberg equilibrium.were not significantly different between the AR and con-
trol subjects (P >0.05) (Table 2).
Similarly, the genotypes of any of the nine selected SNPs
in AR and control were not found to be associated with
AR susceptibility (Table 3). Moreover, age and gender
adjusted logistic regression analyses revealed that in the
codominant-effect model, no significant protective or risk
effects against AR were associated with SNPs in TSLP
gene, compared with wild-type carriers (Table 3), as
assessed by the Akaike’s information criteria (AIC). In
addition, stratified analyses of AR associations demon-
strated no significant associations with any of the selected
SNPs among males or females (data not shown).
LD Analysis and Haplotype Block Structure
Figure 1 shows plots of the pair-wise LD (r2 and D’) values
for the tag SNPs and LD structures in the selected region
of chromosome 5 region (Figure 1-A). Two blocks were
identified in AR vs. control subjects in the selected region
in chromosome 5; of which block 1 encompassed the
50and 30 regions of the TSLP gene as well as the whole
TSLP gene region, whereas block 2 encompassed the 30
region of the TSLP gene (Figure 1-B).c
ion
Base
Change
MAFc Pf P value
for HWEg
test
NCBId Casee Control
ar gene T/G 0.476 0.292 0.278 0.6928 <0.0000
ar gene A/C 0.205 0.284 0.289 0.5036 0.0004
ar gene G/T 0.062 0.104 0.113 0.8689 0.6270
ar gene T/C 0.389 0.467 0.460 0.5430 0.7337
ar gene C/A 0.244 0.154 0.144 0.7575 0.8902
ar gene A/C 0.067 0.050 0.048 0.9790 0.3650
2 C/T 0.211 0.313 0.329 0.8127 0.2428
ar gene A/C 0.144 0.239 0.251 0.6890 0.7148
ar gene G/T 0.089 0.077 0.073 0.9559 0.5559
ar gene G/A 0.337 0.327 0.337 0.8165 0.0635
ar gene T/C 0.411 0.369 0.366 0.6565 0.1416
).
.nih.gov/SNP).
ubjects.
Table 3 Genotype frequencies of 9 tag SNPs among AR and control subjects, and their associations with AR risk
SNP ID Genotype AR subjects Control subjects P
(2 df)a
Logistic regression
No. Frequency No. Frequency OR (95%CI) Pb
rs12653736 GG 290 79.89% 255 78.95% 0.852 1.00 (referent)
GT 66 18.18% 63 19.50% 0.999 (0.667-1.496) 0.996
TT 7 1.93% 5 1.55% 1.073 (0.322-3.572) 0.909
rs1837253 TT 98 26.85% 90 28.66% 0.828 1.00 (referent)
TC 186 50.96% 159 50.64% 1.043 (0.719-1.514) 0.823
CC 81 22.19% 65 20.70% 1.078 (0.686-1.696) 0.744
rs12654933 CC 269 73.30% 237 73.37% 0.659 1.00 (referent)
CA 86 23.43% 79 24.46% 1.012 (0.701-1.463) 0.948
AA 12 3.27% 7 2.17% 1.151 (0.429-3.092) 0.780
rs10455025 AA 333 90.74% 292 90.40% 0.622 1.00 (referent)
AC 33 8.99% 31 9.60% 0.867 (0.503-1.492) 0.605
CC 1 0.27% 0 0.00% NAc NAc
rs11466741 CC 134 46.69% 112 46.67% 0.879 1.00 (referent)
CT 121 42.16% 98 40.83% 0.993 (0.675-1.461) 0.972
TT 32 11.15% 30 12.50% 0.816 (0.454-1.469) 0.498
rs13156086 AA 198 58.24% 169 56.52% 0.909 1.00 (referent)
AC 120 35.29% 110 36.79% 0.903 (0.639-1.277) 0.564
CC 22 6.47% 20 6.69% 0.826 (0.423-1.613) 0.576
rs6886755 GG 317 86.38% 276 85.71% 0.624 1.00 (referent)
GT 47 12.81% 45 13.98% 0.793 (0.501-1.256) 0.323
TT 3 0.82% 1 0.31% 2.535 (0.255-25.235) 0.428
rs252706 GG 163 44.54% 149 46.27% 0.831 1.00 (referent)
GA 155 42.35% 129 40.06% 1.174 (0.837-1.646) 0.353
AA 48 13.11% 44 13.66% 1.120 (0.684-1.832) 0.653
rs2416259 TT 139 38.08% 126 42.14% 0.335 1.00 (referent)
TC 176 48.22% 127 42.47% 1.361 (0.960-1.928) 0.083
CC 50 13.70% 46 15.38% 1.122 (0.689-1.828) 0.644
AR=Allergic rhinitis.
a. Global P values [2 degrees of freedom (df)]: genotype frequencies in AR and control subjects were compared using a χ2 test with 2 df.
b. P values from unconditional logistic regression analyses, adjusted for age and gender.
c. NA, not available because of the rarity of genotype.
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Table 4 summarizes the associations between frequen-
cies of the haplotypes in blocks r rs12654933-
rs11466741-rs13156086 and rs6886755-rs252706 and
the risk of AR. None of the haplotypes investigated was
found to be associated with increased risk of AR in the
cohort studied. Likewise, no association was found be-
tween the diplotypes in the two blocks of AR and AR
risk (Table 5).
Discussion
In this study, we aimed to evaluate the contribution of
SNPs in the TSLP gene towards AR susceptibility in Han
Chinese subjects by employing a population-based case–
control association analysis.Our study demonstrated thatthe allele frequencies for none of the nine tag SNPsse-
lected for AR risk assessment were significantly different
between patients with AR and control subjects. Similarly,
no differences were found between the AR patients and
control subjects for either the genotype distributions of
the selected SNPs or the haplotype frequencies. Overall,
these findings suggest that although the TSLP gene pre-
sents itself as a good candidate involved in the develop-
ment of allergy, this gene is unlikely to be associated with
increased susceptibility to AR in Han Chinese subjects.
The TSLP gene is located on human chromosome
5q22, near the gene cluster encoding T helper (Th) 2
cytokines [29,30], and plays a critical role in Th2 cell dif-
ferentiation [31]. Association studies of allergy related
phenotypes using genetic polymorphisms have been
Figure 1 Graphical representation of the SNP locations and LD structure of the candidate gene. Each figure was composed of
chromosome scale (the top line with even division), the transcription string (the thick bars represent exon (yellow) or UTR (blue), the thin lines
represent intron), SNP scale (the hollow bar with scales representing SNPs location), and graphic of LD (black-and-white) or block definition
(flammulated). The measure of LD (D’) among all possible pairs of SNPs is shown graphically according to the shade of color (A), where white
represents very low D’ and dark represents very high D’. The numbers in squares are D’ values (D’ x 100). The measure of LD (r2) among all
possible pairs of SNPs is shown graphically according to the shade of color (B), where white represents very low r2 and scarlet represents very
high r2. The numbers in squares are r2 values (r2 x 100).
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cent studies showing possible roles of human genetic
polymorphisms of the TSLP gene in allergic diseases.
One study by Harada and colleagues [33] demonstrated
that the SNP rs3806933 in the promoter region of TSLP
created a binding site for the transcription factor activat-
ing protein (AP)-1, and in vitro enhanced AP-1 binding
to the regulatory element. In a more recent study these
authors demonstrated that TSLP gene promoter poly-
morphisms (rs3806933 and rs2289276) were significantly
associated with disease susceptibility in both childhood
atopic and adult asthma [33]. Similarly, Liu and collea-
gues [34] demonstrated that one particular variant of
TSLP (rs1898671) contributed to asthma susceptibility
in admixed urban populations and that the risk of
asthma was significantly increased in ex-smokers; sug-
gesting gene and environment interaction. In contrast, a
large study from Canada demonstrated that variant
rs1837253, which is 5.7 kb upstream of the transcriptionstart site of the TSLP gene, was associated with protec-
tion from asthma, atopic asthma, and airway hyperre-
sponsiveness [35]. More recently, a genome-wide
association study in a Japanese population-based cohort
of adult asthma utilizing fine mapping analysis of the re-
gion on chromosome 5q22 using 13 tag SNPs showed
that rs1837253 represented an associated LD block
spanning 88 kb that included two genes, TSLP and
WDR36. The authors further concluded that TSLP was
the most plausible susceptibility gene in this locus [36].
Similarly, a large consortium-based genome-wide study
has demonstrated significant association between asthma
and several other SNPs [37]. However, with respect to
the association between TSLP polymorphisms and AR,
the study by Bunyavanich and colleagues [16] indicated
that TSLPSNP rs1837253 was associated with reduced
odds for AR in boys with asthma. In the present study,
we selected the representative tag SNPs in and near the
TSLP gene region and the SNPs confirmed to be the
Table 4 Associations between common haplotypes near TSLP gene and AR risk
Block AR
subjects
Control
subjects
Pa Psim
b Hap. Scorec Logistic regression Global score testf
No. Frequency No. Frequency OR (95% CI) Pd
Block1: rs12654933-rs11466741-rs13156086
CCA 382 52.10% 339 52.30% 0.9211 0.6622 0.44067 1.00 (referent) Global-stat = 0.49867,
df = 4, p-val = 0.97363,
Psim
b = 0.97596CTC 180.3 24.60% 165.1 25.50% 0.6940 0.5274 −0.63567 0.933 (0.716-1.217) 0.610
ACA 109 14.90% 91.5 14.10% 0.7014 0.80357 0.25053 1.029 (0.743-1.426) 0.863
CTA 56.5 7.70% 48.4 7.50% 0.8739 0.83692 −0.20715 1.002 (0.604-1.664) 0.993
Others 5.1 0.70% 3.9 0.60% NAe NAe NAe NAe NAe
Block2: rs6886755-rs252706
GG 430.8 58.50% 383.1 58.90% 0.8761 0.70783 −0.37559 1.00 (referent) Global-stat = 0.71243,
df = 2, p-val = 0.70032,
Psim
b = 0.70097GA 252.1 34.30% 219.2 33.70% 0.8355 0.4783 0.70725 1.073 (0.845-1.362) 0.563
TG 53.1 7.20% 47.7 7.30% 0.9336 0.55034 −0.60092 0.913 (0.592-1.408) 0.681
AR=Allergic rhinitis.
a. P value for difference in haplotype frequency between AR and control subjects.
b. Generated by permutation test with 100,000 times simulation.
c. A positive (or negative) score for a particular haplotype would have suggested that the haplotype was associated with increased (or decreased)
risk of allergic rhinitis.
d. P values from unconditional logistic regression analyses, adjusted for age and gender.
e. NA, not available because of the rarity of genotype.
f. df, degrees of freedom.
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ies. In the present study, rs1898671 and rs3806933 were
substituted for rs10455025 and rs12110124 in terms of
the r2value (>0.8), but despite the inclusion of these
main described TSLP variants (rs1837253, rs1898671
and rs3806933) in the adult Han Chinese population, we
were not able to demonstrate any significant association
between these variants and AR susceptibility, similar to
that shown by Bunyavanich and colleagues [16]. How-
ever, unlike the study of Bunyavanich and colleagues
[16] which investigated individuals with comorbid AR
and asthma, a major strength of our study is thatTable 5 Diplotype analysis of common haplotypes near TSLP
Block 0-copy 1-copy logistic regressi
AR/C OR (95%CI) AR/C Pa OR (
Block1: rs12654933-rs11466741-rs13156086
CCA 85/75 1.000 (referent) 167/144 0.583 1.118 (0
CTA 332/294 1.000 (referent) 33/30 0.709 0.902 (0
CTC 208/178 1.000 (referent) 136/126 0.561 0.907 (0
ACA 270/240 1.000 (referent) 86/78 0.869 1.031 (0
Block2: rs6886755-rs252706
GG 67/60 1.000 (referent) 171/147 0.888 1.032 (0
GA 164/149 1.000 (referent) 156/132 0.436 1.143 (0
TG 318/279 1.000 (referent) 47/45 0.342 0.800 (0
AR=Allergic rhinitis subjects; C = control subjects.
a. P values from unconditional logistic regression analyses, adjusted for age and ge
b. Global P values [2 degrees of freedom (df)]: diplotype frequencies in cases and csubjects with AR and asthma were excluded and all sub-
jects in this study only had AR. This is of particular rele-
vance because up to 80% of asthmatics have AR and as
noted from several studies described above, TSLP is a
well replicated asthma susceptibility gene. Thus, it is
possible that the lack of an association between the
TSLP gene and AR susceptibility noted in our study is
an accurate reflection of the real-life situation, because
the TSLP gene is associated with asthma but not AR.
It is of interest that there is evidence which suggests
that gender might modify the role of TSLP in asthma.
Transgenic expression of TSLP in mice leads togene with AR risk
on 2-copy logistic regression P (2 df)b
95%CI) AR/C Pa OR (95%CI)
.750-1.667) 116/106 0.770 1.066 (0.695-1.633) 0.947
.526-1.548) 3/1 0.414 2.606 (0.262-25.927) 0.676
.653-1.260) 24/21 0.739 0.896 (0.468-1.713) 0.884
.714-1.491) 12/7 0.763 1.164 (0.434-3.125) 0.668
.667-1.595) 130/118 0.796 0.942 (0.600-1.480) 0.946
.817-1.600) 48/44 0.678 1.110 (0.679-1.815) 0.893
.505-1.267) 3/1 0.423 2.558 (0.257-25.465) 0.629
nder.
ontrols were compared using a χ2 test with 2 df.
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http://www.biomedcentral.com/1471-2350/13/79perivascular leukocytic infiltration with prominent eo-
sinophilia, with increased severity noted in female mice
compared to malemice [38]. Hunninghake and collea-
gues [39] reported a sex-specific association between a
polymorphism, rs2289276, and serum total IgE in girls
in two independent populations. More recently, these
authors demonstrated that TSLP polymorphisms were
also associated with asthma in a sex-specific fashion
[40]. The T allele of rs1837253 was significantly asso-
ciated with a reduced risk of asthma in males only,
whereas the T allele of rs2289276 was significantly asso-
ciated with a reduced risk of asthma in females only
[40]. However, in stratified analyses of AR associations
with gender, no SNPs showed significant associated
effects among either male nor female groups in present
study.
Despite the possibility that the TSLP gene is generally
not associated with risk of AR, as discussed above, it is
also possible that the discordance noted between the
findings of the present study and previous studies for
any associations between TSLP polymorphisms and risk
of AR [14,16,17], may be a consequence of difference in
study protocols as well as some limitations of the
present study. Firstly, we cannot completely exclude the
possibility that some of our findings are false negative
due to the relative small sample size.It could also be that
SNPs in the TSLP gene region confer a relatively small
risk of developing AR, which we could not detect. Fu-
ture efforts to identify TSLPSNPs carrying a smaller
TSLP risk will thus require a larger sample size than has
been used here. A second consideration is the ethnic
variability in SNP frequency known for the gene. It is
clear that in this study, we have replicated SNPs asso-
ciated in other asthmatic populations and the represen-
tative tag SNPs in terms of the Hapmap CHB population
data, but have not performed extensive fine mapping
studies of the gene which might identify other SNPs with
increased risk. Moreover, as with many other complex
disorders, AR is thought to be the result of a compli-
cated network of numerous susceptibility loci, many of
which exert additive or synergistic effects, but have only
a small role when considered in isolation [41,42]. Fur-
ther studies including genes involved in the Th2 pathway
are needed in larger cohorts of adult Chinese subjects
with AR. However, it is important to note that based on
the current study, a particular TSLP variant alone does
not show a significant association with the development
of AR. Although estimation of TSLP protein in the nasal
mucosa of the subjects would undoubtedly have pro-
vided further direct information in the elucidation of
any association between a TSLP gene variant and sus-
ceptibility/development of AR in this cohort, it was un-
fortunately not possible to accomplish this because of
the difficulty in convincing both the AR and controlsubjects to provide nasal mucosal samples. Moreover, it
was also not possible to perform this aspect of the study
from the ethical aspects.
Conclusion
In conclusion, although TSLP presents itself as a good
candidate for contributing to allergy, particularly asthma,
this study failed to find an association between specific
SNPs in the TSLP gene region and AR susceptibility in
Han Chinese subjects. However, this finding needs to be
confirmed in a larger cohort of patients with only AR.
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